Chang-Chin Wu Selected Research

Chang-Chin Wu Research Topics

Disease

5	Chronic Renal Insufficiency 05/2022 - 01/2020
5	Insulinoma 09/2010 - 11/2008
4	Osteoporosis 06/2021 - 06/2012
3	Inflammation (Inflammations) 05/2022 - 01/2020
3	Bone Resorption 11/2020 - 06/2012
2	Vascular Calcification 05/2022 - 01/2020
2	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 10/2021 - 11/2020
2	Bone Diseases (Bone Disease) 10/2021 - 11/2020
2	Bone Fractures (Bone Fracture) 10/2021 - 01/2021
2	Hypoxia (Hypoxemia) 01/2017 - 05/2010
2	Body Weight (Weight, Body) 08/2013 - 03/2010
1	Hyperparathyroidism 10/2021
1	Sarcopenia 04/2021
1	Cachexia 01/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Malnutrition (Nutritional Deficiencies) 01/2020
1	Congenital Abnormalities (Deformity) 10/2019
1	Femoral Fractures (Femoral Fracture) 10/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2019
1	Rheumatoid Arthritis 11/2018
1	Infections 01/2018
1	Postmenopausal Osteoporosis 01/2017
1	Weight Loss (Weight Reduction) 04/2016
1	Osteoarthritis 01/2016
1	Osteoporotic Fractures 10/2015
1	Necrosis 08/2013
1	Unerupted Tooth 02/2011
1	Hyperglycemia 11/2008
1	Intervertebral Disc Degeneration 08/2008
1	Compression Fractures (Compression Fracture) 12/2007
1	Neurologic Manifestations (Neurological Manifestations) 12/2007
1	Pain (Aches) 12/2007

Drug/Important Bio-Agent (IBA)

5	Sepharose (Agarose)IBA 09/2010 - 11/2008
4	Alkaline PhosphataseIBA 10/2021 - 06/2012
3	MineralsIBA 05/2022 - 11/2020
3	cytidylyl-(3'-5')-cytidine (CpC)IBA 04/2016 - 05/2010
3	calcium phosphateIBA 09/2010 - 03/2010
2	Sulfates (Sulfates, Inorganic)IBA 05/2022 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2021
2	GlucocorticoidsIBA 06/2021 - 10/2019
2	Coloring Agents (Dyes)IBA 01/2020 - 09/2010
2	Collagen Type I (Type I Collagen)IBA 01/2017 - 06/2012
2	OsteocalcinIBA 01/2017 - 06/2012
2	OsteopontinIBA 01/2017 - 02/2011
2	Blood Glucose (Blood Sugar)IBA 08/2013 - 03/2010
2	Insulin (Novolin)FDA Link 09/2010 - 11/2008
2	CytokinesIBA 05/2010 - 11/2008
2	ChitosanIBA 03/2010 - 11/2008
2	HydrogelsIBA 03/2010 - 11/2008
1	EicosanoidsIBA 05/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022
1	InflammasomesIBA 05/2022
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	Uremic ToxinsIBA 10/2021
1	tricalcium phosphateIBA 06/2021
1	CurcuminIBA 04/2021
1	Durapatite (Hydroxylapatite)IBA 04/2021
1	AntioxidantsIBA 04/2021
1	SeleniumIBA 01/2021
1	Therapeutic UsesIBA 11/2020
1	Cinacalcet (Sensipar)FDA Link 11/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 10/2019
1	strontium ranelate (protelos)IBA 10/2019
1	Denosumab FDA Link 10/2019
1	Zoledronic Acid (Zometa)FDA Link 10/2019
1	Diphosphonates (Bisphosphonates)IBA 10/2019
1	Teriparatide (Parathar)FDA Link 10/2019
1	Raloxifene Hydrochloride (Evista)FDA Link 10/2019
1	Bone Density Conservation AgentsIBA 10/2019
1	C-Reactive ProteinIBA 11/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Collagen Type II (Type II Collagen)IBA 01/2017
1	Aggrecans (Aggrecan)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Diphosphates (Pyrophosphates)IBA 01/2017
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2017
1	Collagen Type XIBA 01/2017
1	Hyaluronic Acid (Hyaluronan)IBA 01/2016
1	StrontiumIBA 10/2015
1	Collagen Type IV (Type IV Collagen)IBA 08/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011
1	Oxygen (Dioxygen)IBA 05/2010
1	Glucose (Dextrose)FDA LinkGeneric 03/2010
1	GelatinIBA 11/2008
1	Phosphates (Orthophosphate)IBA 11/2008
1	SolutionsIBA 11/2008

Therapy/Procedure

3	Therapeutics 11/2020 - 08/2008
2	Renal Dialysis (Hemodialysis) 10/2021 - 01/2020
1	Ovariectomy (Oophorectomy) 06/2021
1	Intramuscular Injections 04/2021
1	Surgical Amputation (Amputations) 01/2020
1	Conservative Treatment 10/2019
1	Intra-Articular Injections 01/2016
1	Injections 11/2008
1	Microspheres (Microsphere) 11/2008
1	Decompression 12/2007
1	Vertebroplasty 12/2007
1	Surgical Decompression 12/2007